Linezolid 600 Mg/300 Ml Fresenius 600 mg/300 mL Solution for infusion.
PDF Leaflet Revision Date: 23 July 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible Gram-positive bacteria.
Dosage (summary)
600 mg IV every 12 hours for adults; 10 mg/kg IV every 8 hours for children.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Serotonergic medicines
- MAO inhibitors
- Pethidine
Contraindications
- Hypersensitivity to linezolid
- MAO inhibitors
- Breastfeeding
Common side effects
- Diarrhoea
- Nausea
- Headache
- Insomnia
Counselling Points
- Avoid tyramine-rich foods
- Monitor for visual changes
- Report signs of serotonin syndrome
Serious warnings
- Serotonin syndrome
- Myelosuppression
- Lactic acidosis
Important Disclaimer
The Linezolid 600 Mg/300 Ml Fresenius 600 mg/300 mL Solution for infusion. professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
